ABSTRACT
Case report of an advanced esophageal neuroendocrine carcinoma with hepatic metastasis.
ABSTRACT
Of 50 cases gastric neuroendocrine tumors, in 30 (60%) endoscopic treatment, with relapse rate of 25%, perforation 3,6% and bleeding 7,1%.
Subject(s)
Endoscopic Mucosal Resection , Neuroendocrine Tumors , Stomach Neoplasms , Humans , Neuroendocrine Tumors/diagnostic imaging , Neuroendocrine Tumors/surgery , Neuroendocrine Tumors/pathology , Neoplasm Recurrence, Local , Endoscopy , Stomach Neoplasms/diagnostic imaging , Stomach Neoplasms/surgery , Stomach Neoplasms/pathology , Chronic Disease , Retrospective Studies , Treatment OutcomeABSTRACT
Retrospective study of three cases of MEN type 1 and ZES, to compare with one similar case in publication of The Spanish J of Gastroenterol: MEN-1 and ZES for pancreatic gastrinoma.
ABSTRACT
Analysis of 20 cases of duodenal neuroendocrine tumors (DNET). In 9 cases with 12 DNET, endoscopic treatment with hemorrhage or bleeding of 8,3.
Subject(s)
Duodenal Neoplasms , Endoscopic Mucosal Resection , Neuroendocrine Tumors , Humans , Neuroendocrine Tumors/diagnostic imaging , Neuroendocrine Tumors/surgery , Neuroendocrine Tumors/pathology , Duodenal Neoplasms/diagnostic imaging , Duodenal Neoplasms/surgery , Duodenal Neoplasms/pathology , EndoscopyABSTRACT
No disponible
Subject(s)
Humans , Carcinoma, Neuroendocrine/radiotherapy , Carcinoma, Neuroendocrine/surgery , Carcinoma, Neuroendocrine , Survivorship , Prognosis , Pathology/methods , Endoscopy/methodsABSTRACT
The incidence of gastric and rectal carcinoids is increasing. This is probably due to endoscopic screening. The prognosis is primarily dependent upon tumor size, aggressiveness (pathology, Ki-67), metastatic disease and stage. However, neuroendocrine carcinoma usually behaves as an adenocarcinoma.
Subject(s)
Neuroendocrine Tumors/therapy , Rectal Neoplasms/therapy , Carcinoid Tumor/pathology , Carcinoid Tumor/therapy , Humans , Intestinal Neoplasms/pathology , Intestinal Neoplasms/therapy , Neuroendocrine Tumors/pathology , Prognosis , Rectal Neoplasms/pathology , Survival AnalysisABSTRACT
A review is made of the indications of ultrasonographic contrast enhancement as applied to conventional ultrasonography and endocopic ultrasonography (EUS) as opposed to the use of EUS-sonoelastography today.
Subject(s)
Contrast Media , Digestive System Diseases/diagnostic imaging , Elasticity Imaging Techniques , Algorithms , Cholangiopancreatography, Endoscopic Retrograde , Cholangiopancreatography, Magnetic Resonance , Endosonography , Forecasting , Humans , Sensitivity and Specificity , Ultrasonography, InterventionalABSTRACT
Se efectúa una revisión sobre las indicaciones de los contrastes ecográficos (CE), sonográficos o ultrasónicos aplicados a la ultrasonografía convencional (US) y a la ultrasonografía endoscópica (USE), en contraposición a las aplicaciones que tiene hoy en día la sonoelastografía mediante USE(AU)
A review is made of the indications of ultrasonographic contrast enhancement as applied to conventional ultrasonography and endocopic ultrasonography (EUS) as opposed to the use of EUS-sonoelastography today(AU)